Orthofix Medical has launched its fiberFuse Strip, an advanced demineralised bone-graft solution containing cancellous bone.

The new fiberFuse Strip is a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Orthofix has also announced the first patient implants with the new strip that comprises 100% natural bone.

The fiberFuse Strip comprises mineralised cancellous and demineralised cortical bone fibres, without any carrier, providing an ideal matrix for bone healing.

It creates a natural scaffold to allow for revascularisation, cellular ingrowth and new bone formation.

Orthofix global spine president Kevin Kenny said: “We are pleased to introduce this next-generation formulation in the fiberFUSE allograft line. The fiberFUSE Strip delivers a high-quality advanced bone-graft option in a convenient, easy-to-use strip preparation.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“This technology advancement was developed as part of our strategy to provide procedurally-focused solutions for spine surgeons and their patients.”

The fiberFUSE Strip is exclusively processed by MTF Biologics. Its validated aseptic processing method helps to retain the natural growth factors within the cortical fibres.

The fibres interconnect to form a pliable, cohesive graft, and the cancellous matrix component provides a porous scaffold. It allows ingrowth of vasculature, osteoblasts and mesenchymal stem cells.

Additionally, the fiberFUSE Strip can be rehydrated with the surgeon’s reconstitution solution of choice.

It is also noted that the new strip is for single use in the repair of musculoskeletal defects.

In April, Orthofix announced that the US Food and Drug Administration (FDA) granted 510(k) clearance to its 3D-printed CONSTRUX Mini Ti Spacer System.

The new system is designed to enhance anterior cervical discectomy and fusion procedures.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact